A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina

Health Technol Assess. 2000;4(30):1-95.
No abstract available

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Acetates / therapeutic use
  • Angina, Unstable / drug therapy*
  • Biphenyl Compounds / therapeutic use
  • Cost-Benefit Analysis
  • Eptifibatide
  • Female
  • Humans
  • Male
  • Oximes / therapeutic use
  • Peptides / therapeutic use
  • Piperidines / therapeutic use
  • Platelet Aggregation Inhibitors / economics
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Pyrrolidines / therapeutic use
  • Tirofiban
  • Tyrosine / analogs & derivatives
  • Tyrosine / therapeutic use

Substances

  • Acetates
  • Biphenyl Compounds
  • Oximes
  • Peptides
  • Piperidines
  • Platelet Aggregation Inhibitors
  • Pyrrolidines
  • lefradafiban
  • Tyrosine
  • lamifiban
  • Tirofiban
  • Eptifibatide
  • sibrafiban